Investors > Sangel Capital

Sangel Capital

Sangel Capital is one of the earliest professional biomedical venture capital institutions in China, focusing on the field of life science. Based on the most promising industry, Sangel Capital taps innovative growth enterprises with great capital value and commercial potential, and trains a number of industry benchmarks.Number of Investments: 0